Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Platten

Showing results (271-280 of 318) with videos related to

Pageof 32
Sort By:
The Lancet. Oncology|April 7, 2019
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective studyPhilipp Kickingereder, Fabian Isensee, Irada Tursunova, et al.
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2015
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR TrialMichael Weller, Ghazaleh Tabatabai, Bärbel Kästner, et al.
The Lancet. Digital Health|October 24, 2021
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort studyChandrakanth Jayachandran Preetha, Hagen Meredig, Gianluca Brugnara, et al.
Journal for Immunotherapy of Cancer|November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapyChristina Kober, Julian Roewe, Norbert Schmees, et al.
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for GlioblastomaKirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Neuro-Oncology|December 31, 2025
Multimodality mapping of immunotherapy distribution as a predictive marker in gliomaJonas G Scheck, Berin Boztepe, Julius M Kernbach, et al.
Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
Nature Communications|February 1, 2025
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigenYu-Chan Chih, Amelie C Dietsch, Philipp Koopmann, et al.
Pageof 32

Showing results (271-280 of 318) with videos related to

Sort By:
Pageof 32
The Lancet. Oncology|April 7, 2019
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective studyPhilipp Kickingereder, Fabian Isensee, Irada Tursunova, et al.
Acta Neuropathologica|December 17, 2015
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targetsFelix Sahm, Daniel Schrimpf, David T W Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2015
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR TrialMichael Weller, Ghazaleh Tabatabai, Bärbel Kästner, et al.
The Lancet. Digital Health|October 24, 2021
Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort studyChandrakanth Jayachandran Preetha, Hagen Meredig, Gianluca Brugnara, et al.
Journal for Immunotherapy of Cancer|November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapyChristina Kober, Julian Roewe, Norbert Schmees, et al.
Therapeutic Advances in Neurological Disorders|October 2, 2023
Autologous haematopoietic stem cell transplantation for multiple sclerosis: a position paper and registry outlineAntonios Bayas, Achim Berthele, Norbert Blank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for GlioblastomaKirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Neuro-Oncology|December 31, 2025
Multimodality mapping of immunotherapy distribution as a predictive marker in gliomaJonas G Scheck, Berin Boztepe, Julius M Kernbach, et al.
Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
Nature Communications|February 1, 2025
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigenYu-Chan Chih, Amelie C Dietsch, Philipp Koopmann, et al.
Pageof 32